These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6434296)

  • 1. Disposition of progabide and valproic acid following intraperitoneal administration in rhesus monkey.
    Johno I; Bialer M; Nickelson SA; Levy RH
    Epilepsia; 1984 Oct; 25(5):578-85. PubMed ID: 6434296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic profile of progabide, a new gamma-aminobutyric acid-mimetic drug, in rhesus monkey.
    Johno I; Ludwick BT; Levy RH
    J Pharm Sci; 1982 Jun; 71(6):633-6. PubMed ID: 7097524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic properties of ethosuximide in monkeys. I. Single-dose intravenous and oral administration.
    Patel IH; Levy RH; Bauer TG
    Epilepsia; 1975 Dec; 16(5):705-16. PubMed ID: 816644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys.
    Siefert HM; Maruhn D; Maul W; Förster D; Ritter W
    Arzneimittelforschung; 1986 Oct; 36(10):1496-502. PubMed ID: 3814211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of route of administration and repetitive dosing on the disposition kinetics of di(2-ethylhexyl) phthalate and its mono-de-esterified metabolite in rats.
    Pollack GM; Li RC; Ermer JC; Shen DD
    Toxicol Appl Pharmacol; 1985 Jun; 79(2):246-56. PubMed ID: 4002226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interactions of progabide with other antiepileptic drugs.
    Bianchetti G; Padovani P; Thénot JP; Thiercelin JF; Morselli PL
    Epilepsia; 1987; 28(1):68-73. PubMed ID: 3098557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral, intraperitoneal and intravenous pharmacokinetics of deramciclane and its N-desmethyl metabolite in the rat.
    Nemes KB; Abermann M; Bojti E; Grézal G; Al-Behaisi S; Klebovich I
    J Pharm Pharmacol; 2000 Jan; 52(1):47-51. PubMed ID: 10716602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic profile of valproic acid in rhesus monkeys following single bolus and constant rate intravenous administrations.
    Lai AA; Levy RH; Martis L
    Therapie; 1980; 35(2):221-32. PubMed ID: 6774432
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of dose dependent kinetics of methyl salicylate-2-O-β-D-lactoside in rhesus monkeys after oral administration.
    He Y; Yan Y; Zhang T; Ma Y; Zhang W; Wu P; Song J; Wang S; Du G
    J Ethnopharmacol; 2015 Apr; 164():293-300. PubMed ID: 25571846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and tissue levels of furosemide in dogs and monkeys following single and multiple oral doses.
    Yakatan GJ; Maness DD; Scholler J; Johnston JT; Novick WJ; Doluisio JT
    Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):465-82. PubMed ID: 109903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of valproic acid after oral and parenteral administration in healthy volunteers.
    Nitsche V; Mascher H
    Epilepsia; 1982 Apr; 23(2):153-62. PubMed ID: 6804223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single dose pharmacokinetics and bioavailability of glucosamine in the rat.
    Aghazadeh-Habashi A; Sattari S; Pasutto F; Jamali F
    J Pharm Pharm Sci; 2002; 5(2):181-4. PubMed ID: 12207871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
    Radulovic LL; Türck D; von Hodenberg A; Vollmer KO; McNally WP; DeHart PD; Hanson BJ; Bockbrader HN; Chang T
    Drug Metab Dispos; 1995 Apr; 23(4):441-8. PubMed ID: 7600909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability assessment of cyclosporine in the rat. Influence of route of administration.
    Luke DR; Brunner LJ; Vadiei K
    Drug Metab Dispos; 1990; 18(2):158-62. PubMed ID: 1971566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent kinetics viii: absence of diurnal oscillations in valproic acid disposition following single dose administration to rhesus monkey.
    Levy RH; Viswanathan CT; Lockard JS
    J Pharm Sci; 1982 Jun; 71(6):723-5. PubMed ID: 6808115
    [No Abstract]   [Full Text] [Related]  

  • 17. The pharmacokinetics and bioavailability of a tracer dose of [3H]-mebendazole in man.
    Dawson M; Braithwaite PA; Roberts MS; Watson TR
    Br J Clin Pharmacol; 1985 Jan; 19(1):79-86. PubMed ID: 3978023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic evaluation of novel sustained-release dosage forms of valproic acid in humans.
    Bialer M; Friedman M; Dubrovsky J; Raz I; Abramsky O
    Biopharm Drug Dispos; 1985; 6(4):401-11. PubMed ID: 3936558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition and bioavailability of various formulations of tetrahydrocannabinol in the rhesus monkey.
    Perlin E; Smith CG; Nichols AI; Almirez R; Flora KP; Cradock JC; Peck CC
    J Pharm Sci; 1985 Feb; 74(2):171-4. PubMed ID: 2985774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.